Lindys Schedule5 Mar 2020 17:23
Begins this Monday..........................
Scancell to present at three research conferences, illustrating some of the recent progress on its platform technologies
Scancell Holdings plc, (AIM:SCLP), the developer of novel immunotherapies for the treatment of cancer, announces that its Chief Scientific Officer and Professor of Cancer Immunotherapy at the University of Nottingham, Professor Lindy Durrant, Ph.D., will be presenting at the following three conferences in March 2020:
· The Cambridge Healthcare Institute's (CHI) Immuno-Oncology Summit Europe 2020 in London (9th - 12th March 2020)
Who fancies a blue day tomorrow, and an RNS Monday morning re SCIB1 trial???...............(I do)